Business
Pfizer to supply 40 million shots for poor countries – Sydney Morning Herald
The deal is a boost to the global program known as COVAX, as wealthy nations have snapped up most of the millions of coming shots.
Pfizers 40 million doses for a vaccine requiring two doses are a tiny sliver of whats needed for COVAX, which aims to vaccinate billions of people in 92 low- and middle-income countries.
During Fridays news conference, Tedros said Pfizers commitment and about 150 million doses of the vaccine developed by AstraZeneca and Oxford University could enable COVAX to begin delivering doses in February, pending finalisation of a supply agreement with Pfizer and emergency use approval for AstraZenecas vaccine….
-
Business18 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business14 hours agoDicker Data rides the AI trend to double digit growth
-
Business22 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News15 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference